Log in

Relevant bibliographies by topics / Pharmaceutical development pharmaceutical industry / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Pharmaceutical development pharmaceutical industry.

Dissertations / Theses on the topic 'Pharmaceutical development pharmaceutical industry'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Pharmaceutical development pharmaceutical industry.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Parmar, E. M. "The development and regulation of the Greek pharmaceutical industry." Thesis, Brunel University, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.380615.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Shaw, Brian. "Information systems in pharmaceutical industry research, development and regulation." Thesis, University College London (University of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.313398.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Geng, Fan. "The development strategies for BtoC e-commerce in China's pharmaceutical industry." Thesis, University of Macau, 2008. http://umaclib3.umac.mo/record=b2162725.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Högman, Fredrik. "Managing the development of a functional layout in the pharmaceutical industry." Thesis, Mälardalens högskola, Akademin för innovation, design och teknik, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-39788.

Full text

Abstract:

Laws and regulations are controlling and have generated great impact on the pharmaceutical industry and putting high requirements on production to follow good manufacturing procedures. There is a high pressure on production to decrease the time-to-volume for new products implementations due to the long product development phases where the medicine product patent life only have 35-40% left when production can start. This have generated that production have applied a way of thinking when developing production lines that have a tendency of becoming a scale up over time where a new production line

APA, Harvard, Vancouver, ISO, and other styles

5

Edwards, Francine Elizabeth. "Development of novel microfluidic technologies for use within the pharmaceutical industry." Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/development-of-novel-microfluidic-technologies-for-use-within-the-pharmaceutical-industry(f22e0b81-8379-45da-838f-dccb949d1899).html.

Full text

Abstract:

The high throughput capabilities and low sample volume requirements of microfluidic technology make it an attractive prospect for the pharmaceutical industry. This thesis concerns the development of microfluidic devices to investigate two important challenges to the pharmaceutical industry: to interface microchannel systems with electrospray ionisation mass spectrometry, an extensively used technique in drug discovery and development, and to investigate drug precipitation and its prevention through formulation. A microfluidic electrospray ionisation mass spectrometry interface was developed wh

APA, Harvard, Vancouver, ISO, and other styles

6

Hara, Takuji. "Innovation in the pharmaceutical industry : the process of drug discovery and development /." Cheltenham [u.a.] : Elgar, 2003. http://www.gbv.de/dms/bs/toc/357041208.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Wolf, Sascha G. "Pharmaceutical expenditure in Germany : future development, political influence and economic impact /." Baden-Baden : Nomos, 2009. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=018687182&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Cou, Maria Perpetua. "The international development of pharmaceutical industry of PRC : the role of Macao SAR." Thesis, University of Macau, 2005. http://umaclib3.umac.mo/record=b1447694.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bouché, Cyrille Pierre. "Development of an automated reactor selection and design procedure in the pharmaceutical industry." Thesis, University College London (University of London), 2005. http://discovery.ucl.ac.uk/1444550/.

Full text

Abstract:

The drug market has become very competitive with the development of existing companies and the emergence of new companies. The emergence on the market of so-called generic drugs makes the speed of development of new drugs a prime target. The pharmaceutical industry has until now focused on speeding-up drug development by focusing on the chemistry aspects with very little attention given to potential engineering solutions. When looking at the engineering side of the pharmaceutical industry, and more particularly to the design side of equipment like chemical reactors, the pharmaceutical industry

APA, Harvard, Vancouver, ISO, and other styles

10

Saiz, Balbastre Sandra. "Development and application of analytical techniques for quality control of biologics and sterile pharmaceutical products." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/666802.

Full text

Abstract:

El control microbiològic és essencial en la indústria farmacèutica ja que es tracta d’un indicador de la seguretat dels productes. Els mètodes microbiològics utilitzats a les companyies farmacèutiques per analitzar l’ambient del procés de fabricació així com els productes finals estan basats en mètodes de cultiu tradicional. La tecnologia d’aquests mètodes manca de precisió comparada amb les tecnologies més modernes de detecció i identificació microbiològica. Cada vegada, els requeriments dels controls microbiològics de productes i processos són més estrictes, el que fa que es necessiten mèto

APA, Harvard, Vancouver, ISO, and other styles

11

Griffiths, Robert Ian. "Industrial drug development : application of the theoretical framework of Abernathy, Clark, and Kantrow (1983) in an analysis of factors which determine productivity /." Thesis, This resource online, 1988. http://scholar.lib.vt.edu/theses/available/etd-04122010-083717/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Chang, Ming-lai Lily. "Innovation and technology development in Hong Kong : infrastructure support for Chinese medicine based industry /." Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B2228493X.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Johnson, Otis S. "Evaluating Key Predictors of Employee Response to Change in the Pharmaceutical Industry." ScholarWorks, 2016. https://scholarworks.waldenu.edu/dissertations/2001.

Full text

Abstract:

This study addressed the factors that predict employee response to large-scale change in the United States pharmaceutical industry. When poorly executed, major organizational changes such as mergers and acquisitions are often disruptive and costly to organizations and demoralizing to employees. Although employee responses to change have been studied in several industries, employee responses during change execution in the pharmaceutical industry have not been subject to study. The purpose of this correlational study was to reduce the knowledge gap related to organizational change in the pharmac

APA, Harvard, Vancouver, ISO, and other styles

14

Houston, Chad Allen. "Biotechnology valuation an examination of the drug development pipeline and board of director composition /." View electronic thesis (PDF), 2009. http://dl.uncw.edu/etd/2009-3/r1/houstonc/chadhouston.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Messier, Alexis. "Introducing Continuous Improvement in an R&D Facility : Action research in the pharmaceutical industry." Thesis, Linköpings universitet, Kvalitetsteknik, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-110882.

Full text

Abstract:

Continuous Improvement processes are commonly used by many organizations facing competitive pressure. By implementing continuous incremental changes, it allows optimizing resources while maintaining flexibility. However, it requires significant resources and involvement from all levels of management, as well as field workers. Continuous Improvement is based on the study of processes and the identification of recurrent problems; therefore it is particularly adapted to manufacturing activities and other repetitive processes. R&D (Research and Development) activities are less repetitive and t

APA, Harvard, Vancouver, ISO, and other styles

16

de, Waal Margaret Suzanne. "The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study." Master's thesis, University of Cape Town, 1998. http://hdl.handle.net/11427/17534.

Full text

Abstract:

Includes bibliographical references.<br>Research and development spending has become increasingly important over the last two decades. Despite this, the South African business community has largely ignored the South African accounting standard for research and development costs, AC 122, issued in 1994. A review of the comments received from a number of respondents to the exposure draft to AC 122 and it's international equivalent, lAS 9 (revised), suggests that the implementation difficulties associated with AC 122 are the major reason for the apparent lack of acceptance of AC 122 by the local

APA, Harvard, Vancouver, ISO, and other styles

17

Faydherbe, Sean. "Regional value chains and development integration in the SADC Region: the case of the pharmaceutical industry." Thesis, Rhodes University, 2018. http://hdl.handle.net/10962/62906.

Full text

Abstract:

This thesis investigates how regional value chains (RVCs) can be used to further development integration in the Southern African Development Community (SADC) region with a focus on the pharmaceutical manufacturing industry. The study is motivated by the apparent lack of attention given to the development of the pharmaceutical manufacturing industry in Southern Africa, the region’s high disease burden and the identification of the industry as economically and socially important by the SADC (2015) Industrialisation Strategy and Roadmap and the Department of Trade and Industry (DTI) (2017a) Indus

APA, Harvard, Vancouver, ISO, and other styles

18

Dranitsaris, George. "Development of a value based pricing index for new drugs in metastatic colorectal cancer." Thesis, Nelson Mandela Metropolitan University, 2012. http://hdl.handle.net/10948/d1009310.

Full text

Abstract:

Background: Worldwide, prices for cancer drugs have been under downward pressure where several governments have mandated price cuts of branded and generic products. A better alternative to mandated price cuts would be the estimation of a launch price based on drug performance, cost effectiveness and a country’s ability to pay. In this study, the development of a global pricing index for new drugs that encompasses all of these attributes in patients with metastatic colorectal cancer (mCRC) is described. Methods: A pharmacoeconomic model was developed to simulate clinical outcomes in mCRC patien

APA, Harvard, Vancouver, ISO, and other styles

19

Venter, Gertruida Helena Christina. "The application of new product development principles in the pharmaceutical industry : a comparative study of marketing practitioners' perceptions." Thesis, Stellenbosch : Stellenbosch University, 2001. http://hdl.handle.net/10019.1/52486.

Full text

Abstract:

Thesis (MComm)--Stellenbosch University, 2001.<br>ENGLISH ABSTRACT: New products are indispensable to the growth of the modem business enterprise. Increased global and local competition, better informed consumers, rapidly changing technology and the short life span of products are typical of the reasons why it is necessary to develop new products. Traditionally new product development took place in accordance with a rigid new product development process where a next phase was dependent on the completion of preceding phases. The increased pressure to produce new products in shorter time s

APA, Harvard, Vancouver, ISO, and other styles

20

Nemkyová, Renata. "Intellectual Property and Access to Medicines: Patent Pooling as Access Enabler in Pharmaceutical Industry." Master's thesis, Vysoká škola ekonomická v Praze, 2014. http://www.nusl.cz/ntk/nusl-193645.

Full text

Abstract:

The doctrine of intellectual property is based on the assumption that the exclusivity to commercialize a novel product granted to an inventor creates incentives to conduct research. In some areas, however, intellectual property can constitute a barrier to development of social welfare. In the area of access to medicines in developing countries, the intellectual property-related problem can take two forms. When needed products are not being developed and thus do not exist, lack of availability occurs. Lack of accessibility, on the other hand, arises when necessary medicines do exist, but their

APA, Harvard, Vancouver, ISO, and other styles

21

Folkes, Christina Rosemarie. "Knowledge creation in corporate research and development : an investigation into the approaches and practices employed within the pharmaceutical industry in the United Kingdom at the start of the 21st century." Thesis, n.p, 2006. http://ethos.bl.uk/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Chen, Chen-Chu. "The use of corporate reputation in the development of brand image strategy in the Taiwanese pharmaceutical industry." Thesis, Brunel University, 2011. http://bura.brunel.ac.uk/handle/2438/6135.

Full text

Abstract:

This doctoral research aims to investigate the reputation building process of companies and to examine the applicability of western-developed theories about the uses of corporate reputation in a non-western context. It is the first study that synthesises three theories (value creation, strategic resources and corporate communication) to examine the strategic consequences of the uses of corporate reputation. Corporate reputation is an attribute or a set of attributes ascribed to a firm and inferred from the firm’s past actions. It is the belief of market participants about a firm’s strategic ch

APA, Harvard, Vancouver, ISO, and other styles

23

Sequeira, Keith Patrick. "The patent system and technological development in late industrialising countries : the case of the Spanish pharmaceutical industry." Thesis, University of Sussex, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.263206.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Mauldin, Jo A. Seaman John Weldon. "Bayesian approaches to problems in drug safety and adaptive clinical trial designs." Waco, Tex. : Baylor University, 2008. http://hdl.handle.net/2104/5177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Cong, Ze. "Value of pharmaceutical innovation the access effects, diffusion process, and health effects of new drugs /." Santa Monica: RAND, 2009. http://www.rand.org/pubs/rgs_dissertations/2009/RAND_RGSD242.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Pereira, Carla Raquel Xavier. "The evolving profile, role and relevance of the medical director in a pharmaceutical company." Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/15616.

Full text

Abstract:

Mestrado em Biomedicina Farmacêutica<br>Over the last years, operations in Pharmaceutical Companies have become more complex, trying to adapt to new demands of the market environment. Overall, the observed change of paradigm requires adapting, mainly by the setting of new priorities, diversification of investments, cost containment strategies, exploring new markets and developping new sets of skills. In this context, new functions have been created, the relevance of some has diminished, and the importance of others has arisen. Amongst these, the medical structure within a Pharmaceutical Compan

APA, Harvard, Vancouver, ISO, and other styles

27

Ozdemir, Elif Tuncer. "Patents And Innovation In Pharmaceutical Industry In Turkey: The Comparision Of Patent System With Some Selected Countries." Master's thesis, METU, 2008. http://etd.lib.metu.edu.tr/upload/3/12611892/index.pdf.

Full text

Abstract:

The aim of this thesis is to make policy recommendations for Turkey in order to facilitate innovative activities resulting in more patent applications in pharmaceutical industry through comparing her with the selected countries<br>USA, EU, Japan, India, China and Korea. The comparison is performed in terms of the patent, research and development (R&amp<br>D) expenditures and basic research. This study begins with firstly indicating the relationship between patents and innovation in sector basis. When it is looked at this relationship patents are the most necessary tool for pharmaceutical indus

APA, Harvard, Vancouver, ISO, and other styles

28

Siew, Weiming Eugene. "Application of membrane separation processes in the pharmaceutical industry : a study of process development for overcoming membrane limitations." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/14348.

Full text

Abstract:

The prevalent business model in the pharmaceutical industry requires rapid and robust process development and flexible manufacturing processes. This work reports the attempts to develop structured procedures for membrane process development to meet these requirements. The Donnan Steric Pore Model, in conjunction with a computational molecular dynamics programme, was evaluated as tool for membrane performance predictions to circumvent the need for tedious membrane screening experiments. However, the computational effort required was too onerous, making experimentation more efficient than comput

APA, Harvard, Vancouver, ISO, and other styles

29

Kerdemelidis, Savvas. "Deadly gaps in the patent system : an analysis of current and alternative mechanisms for incentivising development of medical therapies." Thesis, University of Canterbury. School of Law, 2014. http://hdl.handle.net/10092/9826.

Full text

Abstract:

The cost of medicines imposes a significant financial burden on society, with New Zealand spending $783.6 million between 2012 and 2013 alone. The majority of these costs are due to the monopoly prices charged for new patented drugs. The pharmaceutical industry argues that these high prices are necessary to recover the costs of drug development, which can exceed a billion dollars for a single drug. Because new medicines are relatively cheap to reverse-engineer and manufacture, in absence of a minimum period of exclusivity provided by patents, it is alleged that it would not be commercially via

APA, Harvard, Vancouver, ISO, and other styles

30

Rodriguez, Daniel 1965. "Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women." Thesis, Massachusetts Institute of Technology, 1998. http://hdl.handle.net/1721.1/9645.

Full text

Abstract:

Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Economics, 1998.<br>Includes bibliographical references (p. 166-174).<br>This thesis presents two empirical essays, which examine the organization of research and development in the pharmaceutical industry and a third essay that examines the effects of corporate downsizing on the growing number of women in the labor force. Chapter 2 begins by evaluating strategic alliances undertaken in the pharmaceutical industry. The analysis estimates equity market reaction to the announcements of these partnerships and determines how partner

APA, Harvard, Vancouver, ISO, and other styles

31

Dhanraj, Keshnee. "Perceptions of the pharmaceutical industry and regulators in South Africa towards registration harmonisation in the Southern African Development Community (SADC)." University of the Western Cape, 2021. http://hdl.handle.net/11394/7956.

Full text

Abstract:

Magister Pharmaceuticae - MPharm<br>Medicines have to be regulated in an effort to monitor their quality, safety, and efficacy. The process of medicines registration is lengthy, costly, and document-heavy. Many countries have limited expertise and resources at national medicines regulatory authorities (NMRAs) and some countries have adopted unified approaches to medicines registration legislation. Harmonised guidelines and initiatives have been adopted in South Africa and the Southern African Development Community (SADC). However, there are no studies that have identified the effects of

APA, Harvard, Vancouver, ISO, and other styles

32

Cárdenas, Espitia Vanessa. "Development of new analytical methods using Near Infrared and Chemometrics for pharmaceutical quality control: Enhancement of modelling strategies towards a better product understanding." Doctoral thesis, Universitat Autònoma de Barcelona, 2015. http://hdl.handle.net/10803/377466.

Full text

Abstract:

Obtener una alta calidad en la industria farmacéutica es un reto constante que requiere un estricto control y supervisión de los productos manufacturados. La tecnología analítica de procesos (PAT, Process Analytical Technology) propone que esto puede lograrse de una manera óptima y sistematizada mediante el control de calidad en diferentes etapas de manufactura (materias primas, intermedios y producto acabado). La simplicidad y rapidez de la espectroscopía de infrarrojo cercano (NIRS, Near Infrared Spectroscopy) junto con el análisis quimiométrico de datos multivariables ha demostrado

APA, Harvard, Vancouver, ISO, and other styles

33

Dahl, Erik. "Improvement of material supply systems : A case study in a Swedish pharmaceutical company executed on a research and development plant." Thesis, Tekniska Högskolan, Högskolan i Jönköping, JTH, Industriell organisation och produktion, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-41152.

Full text

Abstract:

Material supply systems have for a long time been regarded as an important function with strong potential to increase the performance of companies in different industries. Consequently, substantial research has been conducted in the field. However, in the pharmaceutical industry within research and development plants, material supply systems have historically not been a prioritized function. Therefore, there is a research gap regarding material supply systems in that peculiar context. This study aims to fill that gap by investigating how a material supply system could be designed and which fac

APA, Harvard, Vancouver, ISO, and other styles

34

Piachaud, Bianca Simone. "An investigation into the outsourcing of research and development in the pharmaceutical industry and its impact on conventional thinking about R and D organisation." Thesis, Robert Gordon University, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.340621.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Mukoma, Collins. "Exploration of the Training/Educational Background and The Roles of Regulatory Affairs Associates/Officers in selected South African Based Pharmaceutical Companies in Gauteng Province." University of the Western Cape, 2004. http://hdl.handle.net/11394/8235.

Full text

Abstract:

>Magister Scientiae - MSc<br>Regulatory Affairs (RA), within the pharmaceutical business, could be a profession that covers completely different registration parameters of a pharmaceutical product. This is often a replacement profession that was developed to shield public health by providing the smart quality pharmaceutical product as well as safety and efficacy. The study aimed to explore the coaching and role of RA associates/officers in pharmaceutical corporations in Gauteng, South Africa. The study was a cross-sectional survey, which utilized google forms with both open and closed-ended qu

APA, Harvard, Vancouver, ISO, and other styles

36

Сьомака, А. М. "Фінансове забезпечення розвитку підприємств фармацевтичної галузі". Thesis, Чернігів, 2020. http://ir.stu.cn.ua/123456789/22177.

Full text

Abstract:

Сьомака, А. М. Фінансове забезпечення розвитку підприємств фармацевтичної галузі : магістерська робота : 072 Фінанси, банківська справа та страхування / А. М. Сьомака ; керівник роботи Шишкіна О. В. ; Національний університет «Чернігівська політехніка», кафедра фінансів, банківської справи та страхування. – Чернігів, 2020. – 124 с.<br>В першому розділі розкрито теоретико-методичні засади дослідження фінансового забезпечення підприємств, зокрема визначено сутність поняття «фінансове забезпечення» у контексті функціонування і розвитку підприємств, охарактеризовано основні види, функції та джер

APA, Harvard, Vancouver, ISO, and other styles

37

Palermo, Vincenzo. "Essays on markets for technology: the role of licensing as a complementary strategy to internal R&D." Diss., Georgia Institute of Technology, 2013. http://hdl.handle.net/1853/50241.

Full text

Abstract:

I study the role of licensed technologies in the R&D development process, the knowledge assimilation mechanism and the patent litigation procedure. I document that the use and adoption of licensed technologies is not a linear process and it has important strategic consequences. First, I focus on the joint effect of external and internal technologies and possible firm-level drivers of this relation. I find that, on average, internal R&D and licensing investments are neither complements nor substitutes. However, firms with higher levels of absorptive capacity, economies of scope, and past licens

APA, Harvard, Vancouver, ISO, and other styles

38

Diniz, Paulo Jorge Sampaio. "Inovação na Indústria Farmacêutica Portuguesa de Medicamentos Genéricos." Master's thesis, Instituto Superior de Economia e Gestão, 2011. http://hdl.handle.net/10400.5/3367.

Full text

Abstract:

Mestrado em Gestão e Estratégia Industrial<br>A indústria de medicamentos genéricos assume um papel cada vez mais importante na indústria farmacêutica, na sociedade e na economia, no entanto, apesar da sua evolução muito positiva no mercado, enfrenta desafios importantes que podem condicionar a sua sustentabilidade. A inovação tem sido considerada central para o desenvolvimento, crescimento e competitividade das empresas, contudo Tidd et al. (2003), entre outros, argumentam que não existe um modelo perfeito para gerir o processo de inovação e que este depende das circunstâncias específicas da

APA, Harvard, Vancouver, ISO, and other styles

39

Radaelli, Vanderleia 1977. "Trajetórias inovativas do setor farmacêutico no Brasil : tendências recentes e desafios futuros." [s.n.], 2012. http://repositorio.unicamp.br/jspui/handle/REPOSIP/287652.

Full text

Abstract:

Orientador: Sérgio Robles Reis de Queiroz<br>Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Geociências<br>Made available in DSpace on 2018-08-22T15:26:13Z (GMT). No. of bitstreams: 1 Radaelli_Vanderleia1977-_D.pdf: 2860529 bytes, checksum: ab4b3ed61228154f44fc565ea568bdf1 (MD5) Previous issue date: 2012<br>Resumo: O entendimento da complexa relação entre conhecimento científico, inovação tecnológica e exploração econômica é o principal desafio para indústrias baseadas em ciência como a da farmacêutica. As vantagens competitivas obtidas pelas empresas mais inovadoras dess

APA, Harvard, Vancouver, ISO, and other styles

40

Costa, Magnólia Maria Almeida dos Santos. "I & D e inovação na indústria farmacêutica : o caso português." Master's thesis, Instituto Superior de Economia e Gestão, 1998. http://hdl.handle.net/10400.5/18810.

Full text

Abstract:

Mestrado em Economiae e Gestão de Ciência e Tecnologia<br>A evolução da indústria farmacêutica nas últimas décadas, embora integrando-se no quadro de desenvolvimento global da economia, preserva a sua própria autonomia, devido ao carácter eminentemente social, traduzível nos seus objectivos de combate à doença e à morte, bem como de busca progressiva do bem estar físico e psíquico da humanidade. E porque nesse domínio, nada é imutável, o grau crescente de exigência quanto a níveis de qualidade, de eficácia e de segurança no sector implica uma postura dinâmica e criativa do lado da of

APA, Harvard, Vancouver, ISO, and other styles

41

Chang, Ming-lai Lily, and 張明麗. "Innovation and technology development in Hong Kong: infrastructure support for Chinese medicine basedindustry." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31260202.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Urias, Eduardo Muniz Pereira. "A industria farmaceutica brasileira : um processo de co-evolução de instituições, organizações industriais, ciencia e tecnologia." [s.n.], 2009. http://repositorio.unicamp.br/jspui/handle/REPOSIP/287704.

Full text

Abstract:

Orientadores: Wilson Suzigan, João Eduardo de Moraes Pinto Furtado<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Geociencias<br>Made available in DSpace on 2018-08-13T03:53:36Z (GMT). No. of bitstreams: 1 Urias_EduardoMunizPereira_M.pdf: 794007 bytes, checksum: 1103909e72363b7f6498da306c90d92e (MD5) Previous issue date: 2009<br>Resumo: O presente trabalho possui três objetivos principais, perseguidos por meio de entrevistas com atores da indústria, da coleta de informações em fontes secundárias, de um Painel de Especialistas, somados a elementos teóricos de Econ

APA, Harvard, Vancouver, ISO, and other styles

43

Gusberti, Tomoe Daniela Hamanaka. "Modelo de intervenção para processo de desenvolvimento de produto farmaceutico [sic] para pequenas e médias empresas." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2006. http://hdl.handle.net/10183/8703.

Full text

Abstract:

Os administradores de pequenas e médias empresas (PME) buscam práticas de desenvolvimento de produtos e conhecimento que auxilie a permanência delas e o crescimento no mercado. Uma forma de incorporar práticas consagradas é através da sistematização do Processo de Desenvolvimento de Produto (PDP). A representação desse processo pode ser realizada por meio de modelos referenciais os quais incluem atividades, ferramentas, conceitos e melhores práticas. Apesar disso, no que se refere à estruturação do PDP, de um modo geral, as empresas não incorporaram facilmente essas práticas à sua realidade. E

APA, Harvard, Vancouver, ISO, and other styles

44

Strobeck, Matthew W. (Matthew William) 1972. "The drug development process : evaluation of PDUFA I/II and investigation into reducing drug development times." Thesis, Massachusetts Institute of Technology, 2004. http://hdl.handle.net/1721.1/28592.

Full text

Abstract:

Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology; and, (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and Policy Program, 2004.<br>Includes bibliographical references (p. 59-61).<br>Published findings report that it takes approximately eight years to bring a novel drug to market at an average cost of $800 million. Over the last ten years, the Food and Drug Administration (FDA) has helped to reduce the time from filing a new drug application (NDA) to granting marketing approval (i.e. the approval phase). However, there has been no al

APA, Harvard, Vancouver, ISO, and other styles

45

Amonkou, Anne Cinthia. "Les bases législatives et réglementaires du développement de l'industrie pharmaceutique en Afrique : le cas de la Côte d'Ivoire." Thesis, Strasbourg, 2018. http://www.theses.fr/2018STRAJ115/document.

Full text

Abstract:

Une industrie pharmaceutique locale forte est l’une des assises d’un système sanitaire efficace. L’objectif de ce travail est de contribuer à l’optimisation du cadre juridique en vue de l’essor de ce secteur d’activités en Côte d’Ivoire. Partant d’une description des textes législatifs et réglementaires applicables à l’industrie pharmaceutique, nous avons recherché et analysé les facteurs qui conditionnent le développement du secteur et enfin avons formulé des axes d’optimisation. Le corpus juridique ivoirien sur l’industrie pharmaceutique en vigueur définit un cadre normatif, institutionnel e

APA, Harvard, Vancouver, ISO, and other styles

46

Radaelli, Vanderleia 1977. "A inovação na industria farmaceutica : forças centripetas e forças centrifugas no processo de internacionalização." [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/286824.

Full text

Abstract:

Orientador: João Eduardo de Moraes Pinto Furtado<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Geociencias<br>Made available in DSpace on 2018-08-07T20:18:38Z (GMT). No. of bitstreams: 1 Radaelli_Vanderleia1977-_M.pdf: 1695703 bytes, checksum: b5fb9c7709eec560328997829b830c9c (MD5) Previous issue date: 2006<br>Resumo: A presente dissertação trata da indústria farmacêutica e das transformações estruturais na sua cadeia de valor, que têm produzido impactos variados entre os atores e instituições que a integram. Centrado na análise das atividades tecnológicas, o tr

APA, Harvard, Vancouver, ISO, and other styles

47

Filho, Silvio Barberato. "Pesquisa e desenvolvimento de fármacos no Brasil: estratégias de fomento." Universidade de São Paulo, 2006. http://www.teses.usp.br/teses/disponiveis/9/9138/tde-17092006-020055/.

Full text

Abstract:

Pode-se afirmar que no século XX originou-se uma indústria farmacêutica multinacional com extraordinária capacidade de pesquisa e desenvolvimento para produzir novos fármacos. Porém, contradizendo este potencial inovador, o número de fármacos introduzidos no mercado vem declinando desde 1960 e as oportunidades abertas com os avanços da biologia molecular, da genômica, da bioinformática e da química ainda não trouxeram os resultados esperados. No Brasil, a pesquisa científica tem obtido resultados de grande relevância, mas encontra muitas dificuldades para levar novos produtos ao mercado. O obj

APA, Harvard, Vancouver, ISO, and other styles

48

Singh, Sauman. "Entry and operation strategies of Indian pharmaceutical firms in Africa under the dynamics of markets and institutions." Thesis, Aix-Marseille, 2018. http://www.theses.fr/2018AIXM0238/document.

Full text

Abstract:

La thèse démontre que l'environnement protectionniste en Inde a contribué à bâtir une industrie pharmaceutique solide. L'arrivée simultanée de l'Accord ADPIC et de la libéralisation économique a créé des « push factors » à la fois compétitifs et favorables, obligeant les firmes pharmaceutiques indiennes (FPI) à chercher de nouvelles voies de croissance à l’étranger. Les politiques des pays africains en faveur des génériques, l’action des organisations internationales et la nouvelle gouvernance des marchés financés par les bailleurs de fonds ont aussi induits des « pull factors » permettant aux

APA, Harvard, Vancouver, ISO, and other styles

49

Schaefer, Cédric. "A Process Analytical Technology (PAT) approach involving near infrared spectroscopy to control the manufacturing of an active pharmaceutical ingredient : development, validation and implementation." Electronic Thesis or Diss., Aix-Marseille, 2013. http://www.theses.fr/2013AIXM4375.

Full text

Abstract:

Les entreprises pharmaceutiques ont progressivement adopté le concept de Process Analytical Technology (PAT) afin de contrôler et d'assurer en temps réel la qualité des produits pharmaceutiques au cours de leur production. Le PAT et un composant central du concept plus général de Quality-by-Design (QbD) promu par les agence régulatrices et visant à construire la qualité des produits via une approche scientifique et la gestion des risques.Une méthode basée sur la spectroscopie proche infrarouge (PIR) a été développée comme un outil du PAT pour contrôler en ligne la cristallisation d'un principe

APA, Harvard, Vancouver, ISO, and other styles

50

Abbas, Muhammad Zaheer. "Community-based patent opposition model in India: Access to medicines, right to health and sustainable development." Thesis, Queensland University of Technology, 2020. https://eprints.qut.edu.au/180843/1/Muhammad%20Zaheer_Abbas_Thesis.pdf.

Full text

Abstract:

Jeffrey Sachs' conceptions of enlightened globalization and directed technological change are relevant to patent law and access to medicines in India. This study was original in translating these concepts into a concrete and integrated package of patent law and policy reform proposals for India. This study presented new empirical data and undertook statistical analysis of India's patent opposition model. In light of Sachs' ideas, this project proposed a community-based patent opposition model as a novel solution complemented by other measures and policies like need-driven collaborative open in

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!